Ekert Jason E, Murray Lynne A, Das Anuk M, Sheng Hai, Giles-Komar Jill, Rycyzyn Michael A
Departments of Cell Biology and Assay Technologies, Centocor R&D, a division of Johnson & Johnson Pharmaceutical Research & Development, LLC, Radnor, PA, USA.
Department of Immunology, Centocor R&D, a division of Johnson & Johnson Pharmaceutical Research & Development, LLC, Radnor, PA, USA.
Fibrogenesis Tissue Repair. 2011 Oct 19;4(1):23. doi: 10.1186/1755-1536-4-23.
Fibrocytes are a population of circulating bone-marrow-derived cells that express surface markers for leukocytes and mesenchymal cells, and are capable of differentiating into myofibroblasts. They have been observed at sites of active fibrosis and increased circulating numbers correlate with mortality in idiopathic pulmonary fibrosis (IPF). Inhibition of chemokine (C-C motif) receptor 2 (CCR2) during experimental models of lung fibrosis reduces lung collagen deposition, as well as reducing lung fibrocyte accumulation. The aim of the present study was to determine whether human and mouse fibrocytes express functional CCR2.
Following optimized and identical human and murine fibrocyte isolation, both cell sources were shown to be positive for CCR2 by flow cytometry and this expression colocalized with collagen I and CD45. Human blood fibrocytes stimulated with the CCR2 ligand chemokine (C-C motif) ligand 2 (CCL2), demonstrated increased proliferation (P < 0.005) and differentiation into myofibroblasts (P < 0.001), as well as a chemotactic response (P < 0.05). Murine fibrocytes also responded to CCR2 stimulation, with CCL12 being more potent than CCL2.
This study directly compares the functional responses of human and murine fibrocytes to CCR2 ligands, and following comparable isolation techniques. We have shown comparable biological effects, strengthening the translatability of the murine models to human disease with respect to targeting the CCR2 axis to ameliorate disease in IPF patients.
纤维细胞是一群循环的骨髓来源细胞,表达白细胞和间充质细胞的表面标志物,并且能够分化为肌成纤维细胞。在活动性纤维化部位已观察到它们,且特发性肺纤维化(IPF)患者循环中纤维细胞数量增加与死亡率相关。在肺纤维化实验模型中,抑制趋化因子(C-C基序)受体2(CCR2)可减少肺胶原沉积以及减少肺纤维细胞积聚。本研究的目的是确定人和小鼠纤维细胞是否表达功能性CCR2。
经过优化且相同的人和小鼠纤维细胞分离后,通过流式细胞术显示两种细胞来源的CCR2均呈阳性,且这种表达与I型胶原和CD45共定位。用人CCR2配体趋化因子(C-C基序)配体2(CCL2)刺激人血纤维细胞,结果显示其增殖增加(P<0.005),分化为肌成纤维细胞(P<0.001),并且有趋化反应(P<0.05)。小鼠纤维细胞也对CCR2刺激有反应,CCL12比CCL2更有效。
本研究在可比的分离技术之后,直接比较了人和小鼠纤维细胞对CCR2配体的功能反应。我们已经显示出可比的生物学效应,在针对CCR2轴改善IPF患者疾病方面,加强了小鼠模型对人类疾病的可转化性。